Cargando…
Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model
BACKGROUND: Ten to 30% of HIV-1 infected subjects develop broadly neutralizing antibodies (bNAbs) during chronic infection. We hypothesized that immunizing rabbits with viral envelope glycoproteins (Envs) from these patients may induce bNAbs, when formulated as a trimeric protein and in the presence...
Autores principales: | Heyndrickx, Leo, Stewart-Jones, Guillaume, Jansson, Marianne, Schuitemaker, Hanneke, Bowles, Emma, Buonaguro, Luigi, Grevstad, Berit, Vinner, Lasse, Vereecken, Katleen, Parker, Joe, Ramaswamy, Meghna, Biswas, Priscilla, Vanham, Guido, Scarlatti, Gabriella, Fomsgaard, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759472/ https://www.ncbi.nlm.nih.gov/pubmed/24023951 http://dx.doi.org/10.1371/journal.pone.0074552 |
Ejemplares similares
-
Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
por: Heyndrickx, L, et al.
Publicado: (2012) -
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
por: Visciano, Maria Luisa, et al.
Publicado: (2013) -
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques
por: Borggren, Marie, et al.
Publicado: (2013) -
Viral vector delivery of Env trimer immunogens
por: Parks, CL, et al.
Publicado: (2012) -
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
por: Aldon, Yoann, et al.
Publicado: (2021)